Cannabis Research Is Undermined by Inconsistent Definitions of 'Cannabis User'
A commentary exposes how cannabis research is weakened by wildly inconsistent definitions — 'heavy use' ranges from monthly to daily across studies — calling for urgent standardization to enable meaningful evidence synthesis.
Quick Facts
What This Study Found
Current research methods lack consistency in defining cannabis use variables (e.g., 'occasional' and 'heavy' use vary from monthly to daily). Methods fail to capture form (flower, concentrate, edibles), dose, and cannabinoid content. Self-report biases, inadequate health codes, and inaccurate biological tests all contribute to poor user identification.
Key Numbers
Key inconsistencies: 'heavy use' defined as monthly to daily across studies. Missing variables: form, dose, THC/CBD content, lifetime use patterns. Methods failing: self-report (biased), ICD codes (no general use code), biological tests (inaccurate windows).
How They Did This
Commentary reviewing correlational studies on cannabis outcomes to assess methods for identifying and characterizing users. Compared survey tools, self-report measures, health records, and biochemical assays. Reviewed existing frameworks for cannabis use characterization.
Why This Research Matters
If we can't consistently define who a 'cannabis user' is, we can't accurately assess risks, benefits, or outcomes. This undermines every study — from safety to therapeutic potential — and makes it nearly impossible to compare findings across research teams.
The Bigger Picture
This is a foundational problem for the entire field of cannabis research. Without solving it, the evidence base for cannabis policy, medical recommendations, and public health guidance will remain unreliable — regardless of how many studies are conducted.
What This Study Doesn't Tell Us
Commentary, not empirical study. Doesn't provide a fully developed standardized framework (calls for one). Some inconsistency may be inherent to the complexity of cannabis use patterns.
Questions This Raises
- ?Can a universal cannabis use taxonomy be developed?
- ?Would a standardized survey tool gain international adoption?
- ?How can biological testing be improved to reflect actual use patterns?
Trust & Context
- Key Stat:
- Evidence Grade:
- Expert commentary identifying a well-documented methodological problem — persuasive but does not itself solve the issue.
- Study Age:
- Published in 2026, addressing a growing problem as cannabis research volume increases without standardization.
- Original Title:
- What is a "Cannabis User"?
- Published In:
- Clinical therapeutics, 48(1), 22-28 (2026)
- Authors:
- Fisher, Ruth
- Database ID:
- RTHC-08264
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
Why can't we trust cannabis research comparisons?
Because studies define 'cannabis user' differently — one study's 'heavy user' (monthly) is another's 'occasional user.' Without consistent definitions, comparing findings is like comparing apples to oranges.
How could this be fixed?
The commentary calls for standardized surveys that capture form, dose, cannabinoid content, and lifetime patterns, plus assurance that participants can report honestly without legal consequences. An international consensus on definitions is urgently needed.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-08264APA
Fisher, Ruth. (2026). What is a "Cannabis User"?. Clinical therapeutics, 48(1), 22-28. https://doi.org/10.1016/j.clinthera.2025.11.003
MLA
Fisher, Ruth. "What is a "Cannabis User"?." Clinical therapeutics, 2026. https://doi.org/10.1016/j.clinthera.2025.11.003
RethinkTHC
RethinkTHC Research Database. "What is a "Cannabis User"?" RTHC-08264. Retrieved from https://rethinkthc.com/research/fisher-2026-what-is-a-cannabis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.